High-flow nasal oxygen vs. conventional oxygen therapy in patients with COVID-19 related acute hypoxemic respiratory failure and a do not intubate order: a multicentre cohort study

High-flow nasal oxygen vs. conventional oxygen therapy in patients with COVID-19 related acute hypoxemic respiratory failure and a do not intubate order: a multicentre cohort study

Abstract Background High-flow nasal oxygen (HFNO) is frequently used to treat patients with acute hypoxemic respiratory failure (AHRF) due to viral pneumonia, including COVID-19. However, its clinical effect compared to conventional oxygen therapy (COT) remains largely unexplored in patients with a...

Full description

Saved in:
Bibliographic Details
Main Authors: Daphne J. T. Sjauw, Lisa M. Hessels, Marieke L. Duiverman, Judith Elshof, Matthijs L. Janssen, Yasemin Türk, Leo Heunks, Sara J. Baart, Evert-Jan Wils, Dutch HFNO study group, NORMO2 project group
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Respiratory Research
Subjects:
Acute hypoxemic respiratory failure
Conventional oxygen therapy
COVID-19
Do not intubate order
High-flow nasal oxygen
Online Access:https://doi.org/10.1186/s12931-025-03231-8
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12931-025-03231-8

Similar Items